|
Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation
RECRUITINGSponsored by Kardium Inc.
Actively Recruiting
SponsorKardium Inc.
Started2026-10-09
Est. completion2029-10
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT07651852
Summary
This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).
Eligibility
Age: 18 Years+Healthy volunteers accepted
Key Inclusion Criteria: * Patients with a planned ablation procedure using the commercially available Globe PF System Key Exclusion Criteria: * Patients whose life expectancy is 1 year or less * Contraindication to left atrial catheter ablation or PF ablation * Current enrollment in any investigational study of a medical device, biologic, or drug not pre-approved by Kardium
Conditions2
Atrial FibrillationHeart Disease
Locations2 sites
Arkansas
1 siteWashington
1 siteFind trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorKardium Inc.
Started2026-10-09
Est. completion2029-10
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT07651852